Low levels of IgM antibodies against phosphorylcholine predict development of coronary artery disease in a population based cohort

被引：0
|
作者：
Frostegard, J. [1 ]
Gronlund, H. [1 ]
Hallmans, G. [2 ]
Jansson, J. H. [2 ]
Boman, K. [2 ]
Wikstrom, M. [1 ]
Dahlbom, I. [3 ]
Lettesjo, H. [4 ]
De Faire, U. [1 ]
机构：
[1] Karolinska Inst, Stockholm, Sweden
[2] Umea Univ, Umea, Sweden
[3] Uppsala Univ, Uppsala, Sweden
[4] Athera Biotechnol AB, Stockholm, Sweden
来源：
EUROPEAN HEART JOURNAL | 2009年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：774 / 774
页数：1
相关论文
共 50 条
  • [1] Low levels of IgM antibodies against phosphorylcholine predict development of coronary artery disease in a population based cohort from Northern Sweden
    Dahlbom, I.
    Gronlund, H.
    Hallmans, G.
    Jansson, J. H.
    Boman, K.
    Wikstrom, M.
    Lettesjo, H.
    de Faire, U.
    Frostegard, J.
    CLINICAL CHEMISTRY, 2009, 55 (06) : A58 - A58
  • [2] Low levels of IgM antibodies against phosphorylcholine predict development of acute myocardial infarction in a population-based cohort from northern Sweden
    Gronlund, Hans
    Hallmans, Goran
    Jansson, Jan Hakan
    Boman, Kurt
    Wikstrom, Max
    de Faire, Ulf
    Frostegard, Johan
    EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION, 2009, 16 (03): : 382 - 386
  • [3] Low levels of IgM antibodies to phosphorylcholine predict cardiovascular disease in men
    Frostegard, J.
    Su, J.
    Hua, X.
    Cederholm, A.
    Halldin, M.
    Hellenius, M.
    Gronlund, H.
    Dahlbom, I.
    Lettesjo, H.
    De Faire, U.
    EUROPEAN HEART JOURNAL, 2009, 30 : 773 - 773
  • [4] Low levels of natural IgM antibodies against phosphorylcholine are independently associated with vascular remodeling in patients with coronary artery disease
    Gleissner, Christian A.
    Erbel, Christian
    Haeussler, Julia
    Akhavanpoor, Mohammadreza
    Domschke, Gabriele
    Linden, Fabian
    Doesch, Andreas O.
    Conradson, Goeran
    Buss, Sebastian J.
    Hofmann, Nina P.
    Gitsioudis, Gitsios
    Katus, Hugo A.
    Korosoglou, Grigorios
    CLINICAL RESEARCH IN CARDIOLOGY, 2015, 104 (01) : 13 - 22
  • [5] Low levels of natural IgM antibodies against phosphorylcholine are independently associated with vascular remodeling in patients with coronary artery disease
    Christian A. Gleissner
    Christian Erbel
    Julia Haeussler
    Mohammadreza Akhavanpoor
    Gabriele Domschke
    Fabian Linden
    Andreas O. Doesch
    Göran Conradson
    Sebastian J. Buss
    Nina P. Hofmann
    Gitsios Gitsioudis
    Hugo A. Katus
    Grigorios Korosoglou
    Clinical Research in Cardiology, 2015, 104 : 13 - 22
  • [6] Low levels of antibodies against phosphorylcholine predict development of atherosclerosis
    Frostegard, J.
    Sjoberg, B.
    Su, J.
    Gronlund, H.
    Dahlbom, I.
    Hedblad, B.
    Berglund, G.
    de Faire, U.
    CLINICAL CHEMISTRY, 2008, 54 (06) : A153 - A153
  • [7] LOW LEVELS OF ANTIBODIES AGAINST PHOSPHORYLCHOLINE PREDICT DEVELOPMENT OF ATHEROSCLEROSIS
    Frostegard, J.
    Sjoberg, B.
    Su, J.
    Gronlund, H.
    Dahlbom, I.
    Hedblad, B.
    Berglund, G.
    de Faire, U.
    ATHEROSCLEROSIS SUPPLEMENTS, 2008, 9 (01) : 78 - 78
  • [8] Low levels of IgM antibodies to phosphorylcholine predict cardiovascular disease in men.
    Dahlbom, I.
    Su, J.
    Hua, X.
    Cederholm, A.
    Halldin, M.
    Hellenius, M.
    Wikstrom, M.
    Lettesjo, H.
    Gronlund, H.
    Frostegard, J.
    de Faire, U.
    CLINICAL CHEMISTRY, 2009, 55 (06) : A57 - A57
  • [9] LOW LEVELS OF NATURAL ANTIBODIES AGAINST PHOSPHORYLCHOLINE PREDICT DEVELOPMENT OF STROKE
    Fiskesund, R.
    Stegmayr, B.
    Hallmans, G.
    de Faire, U.
    Frostegard, J.
    ATHEROSCLEROSIS SUPPLEMENTS, 2009, 10 (02)
  • [10] Low Levels of Antibodies Against Phosphorylcholine Predict Development of Stroke in a Population-Based Study From Northern Sweden
    Fiskesund, Roland
    Stegmayr, Birgitta
    Hallmans, Goran
    Vikstrom, Max
    Weinehall, Lars
    de Faire, Ulf
    Frostegard, Johan
    STROKE, 2010, 41 (04) : 607 - 612
12345